AIF1 and autism: We further evaluated the effect of autism sera treatment on two markers of neuroinflammation i.e., glial fibrillary acidic protein, GFAP, a marker of astrocytes, and Iba1, a marker of microglia, in the cerebral cortex of young rats by Western blots.